Growth and sexual maturation in a 2-year, open-label clinical study of lisdexamfetamine dimesylate in children and adolescents with ADHD

被引：0
|
作者：
Otero, I. Hernandez [1 ]
Banaschewski, T. [2 ]
Johnson, M. [3 ]
Nagy, P. [4 ,5 ,6 ]
Soutullo, C. A. [7 ]
Zuddas, A. [8 ]
Yan, B. [9 ]
Coghill, D. R. [10 ]
机构：
[1] Hosp Virgen de la Victoria, Unit Child & Adolescent Mental Hlth USMIJ, Malaga, Spain
[2] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Child & Adolescent Psychiat & Psychotherapy, Mannheim, Germany
[3] Gothenburg Univ, Sahlgrenska Acad, Gillberg Neuropsychiat Ctr, Gothenburg, Sweden
[4] Vadaskert Child & Adolescent Psychiat Hosp, Budapest, Hungary
[5] Vadaskert Child & Adolescent Psychiat Hosp, Outpatient Clin, Budapest, Hungary
[6] Outpatient Clin, Budapest, Hungary
[7] Univ Navarra Clin, Child & Adolescent Psychiat Unit, Dept Psychiat & Med Psychol, Pamplona, Spain
[8] Univ Cagliari, Dept Biomed Sci, Child & Adolescent Neuropsychiat Unit, Cagliari, Italy
[9] Shire, Lexington, MA USA
[10] Univ Dundee, Div Neurosci, Dundee, Scotland
来源：
EUROPEAN PSYCHIATRY | 2017年 / 41卷
关键词：
D O I：
10.1016/j.eurpsy.2017.01.1943
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EW0074
引用
收藏
页码：S130 / S130
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of lurasidone in children and adolescents with bipolar depression: Results from a 2-year open-label extension study
    DelBello, M. P.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S236 - S236
  • [22] EFFECTIVENESS OF MAZINDOL IN CHILDREN WITH ADHD : OPEN-LABEL STUDY
    Konofal, E.
    Lecendreux, M.
    Kaguelidou, F.
    Mentre, F.
    Laouenan, C.
    Jacqz-Aigrain, E.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [23] Effectiveness, Safety, and Tolerability of Lisdexamfetamine Dimesylate in Children With Attention-Deficit/Hyperactivity Disorder: An Open-Label, Dose-Optimization Study
    Findling, Robert L.
    Ginsberg, Lawrence D.
    Jain, Rakesh
    Gao, Joseph
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2009, 19 (06) : 649 - 662
  • [24] EFFECT OF LURASIDONE ON COGNITION IN ADOLESCENTS WITH SCHIZOPHRENIA: INTERIM ANALYSIS OF A 2-YEAR OPEN-LABEL EXTENSION STUDY
    Harvey, Philip D.
    Goldman, Robert
    Tocco, Michael
    Deng, Ling
    Cucchiaro, Josephine
    Loebel, Antony
    SCHIZOPHRENIA BULLETIN, 2018, 44 : S353 - S353
  • [25] Risperidone in children with disruptive behavior disorders: A 2-year open-label trial
    Reyes-Harde, M
    Croonenberghs, J
    Eerdekens, M
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S274 - S274
  • [26] A Long-Term Open-Label Safety and Effectiveness Trial of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder
    Findling, Robert L.
    Cutler, Andrew J.
    Saylor, Keith
    Gasior, Maria
    Hamdani, Mohamed
    Ferreira-Cornwell, M. Celeste
    Childress, Ann C.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2013, 23 (01) : 11 - 21
  • [27] Efficacy of long-term treatment with lurasidone in children and adolescents with bipolar depression: Interim analysis of a 2-year open-label study
    DelBello, M. P.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S368 - S368
  • [28] A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults
    Richards, Cynthia
    Iosifescu, Dan V.
    Mago, Rajnish
    Sarkis, Elias
    Geibel, Brooke
    Dauphin, Matthew
    McIntyre, Roger S.
    Weisler, Richard
    Brawman-Mintzer, Olga
    Gu, Joan
    Madhoo, Manisha
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2018, 38 (04) : 336 - 343
  • [29] Health-related quality of life outcomes in a long-term study of lisdexamfetamine dimesylate in children and adolescents with ADHD
    Coghill, D.
    Banaschewski, T.
    Zuddas, A.
    Johnson, M.
    Hodgkins, P.
    Adeyi, B.
    Squires, L.
    Civil, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S598 - S599
  • [30] Safety and effectiveness of lurasidone in adolescents with schizophrenia: A one-year interim analysis of a 2-year open-label extension study
    Correll, C.
    Tocco, M.
    Goldman, R.
    Pikalov, A.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2018, 48 : S127 - S127
12345